Two recent papers studying BRAF alterations in PCa
Recently two papers have been published about BRAF alterations in prostate cancer:
Unique Spectrum of Activating BRAF Alterations in Prostate Cancer.
Authors: Alex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, Smruthy Sivakumar, Alexa B. Schrock, Hannah E. Bergom, Hedyeh Ebrahimi, Sumanta Pal, Tanya Dorff, Neeraj Agarwal, Brandon A. Mahal, Geoffrey R. Oxnard, Justin Hwang, Emmanuel S. Antonarakis.
Targeting the multifaceted BRAF in cancer: New directions.
Authors: Eamon Toye, Alexander Chehrazi-Raffle, Justin Hwang, Emmanuel S. Antonarakis.
Emmanuel Antonarakis, Professor of Medicine at the University of Minnesota, who is co-author in both studies, shared a post on X:
”Congratulations Eamon Toye and Alex Chehrazi-Raffle on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered cancers, PCa is characterized by Class II muts and activating fusions, including AR-regulated BRAF fusions.”
Source: Emmanuel Antonarakis/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023